NORDIC BIOTECH HOLDING ApS: Financial statements 2017
CVR: 26409683
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 130,146 and a net result of DKK 1,063,456 compared with DKK -81,717 the year before. Equity in the 2017 report amounted to DKK 191,489. The solvency ratio was 14.9%.
- Gross Profit
- DKK 130,146
- Profit/Loss
- DKK 1,063,456
- Equity
- DKK 191,489
- Total Assets
- DKK 1,285,173
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 130K | 1.1M | 191K | - |
| 2016 | - | -36K | -82K | -872K | - |
| 2015 | - | -88K | -165K | -790K | - |
| 2014 | - | -392K | -489K | -547K | - |
| 2013 | 0 | -115K | -177K | -57K | - |
Official annual report
Keep an eye on NORDIC BIOTECH HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NORDIC BIOTECH HOLDING ApS has published its annual report for 2016. Gross profit came to DKK -35,916, and the net result was DKK -81,717.
About NORDIC BIOTECH HOLDING ApS
NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.